Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

A man's skin condition was misdiagnosed and later identified as a rare type of skin cancer, which did not improve with treatment.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

CMV infection increases the risk of GvHD after bone marrow transplants.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Tislelizumab can cause cutaneous lupus erythematosus.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.